-
EP3464312
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3464312
| EP3464312 - ANIMAL AND HUMAN ANTI-TRYPANOSOMONAL AND ANTI-LEISHMANIA AGENTS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 04.03.2022 Database last updated on 06.07.2024 | |
| Former | Request for examination was made Status updated on 08.03.2019 | ||
| Former | The international publication has been made Status updated on 08.12.2017 | Most recent event Tooltip | 18.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Celgene Corporation Route 206 & Province Line Road Princeton, NJ 08543 / US | [2024/14] |
| Former [2019/15] | For all designated states Celgene Corporation 86 Morris Avenue Summit, NJ 07901 / US | Inventor(s) | 01 /
CANAN, Stacie, S. 5940 La Jolla Mesa Drive La Jolla CA 92037 / US | 02 /
HAWRYLUK, Natalie, Anne 4379 Mistral Pl. San Diego CA 92130 / US | 03 /
WITTY, Michael, John 2 Bridleway Whitfield Dover Kent CT16 3NH / GB | [2019/15] | Representative(s) | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11 80538 München / DE | [2019/15] | Application number, filing date | 17807469.6 | 01.06.2017 | [2019/15] | WO2017US35413 | Priority number, date | US201662344759P | 02.06.2016 Original published format: US 201662344759 P | [2019/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017210408 | Date: | 07.12.2017 | Language: | EN | [2017/49] | Type: | A1 Application with search report | No.: | EP3464312 | Date: | 10.04.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.12.2017 takes the place of the publication of the European patent application. | [2019/15] | Search report(s) | International search report - published on: | US | 07.12.2017 | (Supplementary) European search report - dispatched on: | EP | 28.10.2019 | Classification | IPC: | C07H21/02, C12N15/11 | [2019/15] | CPC: |
A61K45/06 (EP,US);
A61K31/52 (US);
A61P33/02 (EP);
A61P43/00 (EP);
C07C211/36 (US);
C07C211/57 (US);
C07D413/02 (EP,US);
C07D473/32 (EP,US);
C07C13/06 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/15] | Title | German: | TIERISCHE UND MENSCHLICHE ANTI-TRYPANOSOMONAL- UND ANTI-LEISHMANIA-MITTEL | [2019/15] | English: | ANIMAL AND HUMAN ANTI-TRYPANOSOMONAL AND ANTI-LEISHMANIA AGENTS | [2019/15] | French: | AGENTS ANTI-TRYPANOSOMES ET ANTI-LEISHMANIA POUR ANIMAUX ET HUMAINS | [2019/15] | Entry into regional phase | 28.11.2018 | National basic fee paid | 28.11.2018 | Search fee paid | 28.11.2018 | Designation fee(s) paid | 28.11.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 28.11.2018 | Examination requested [2019/15] | 11.05.2020 | Amendment by applicant (claims and/or description) | 07.03.2022 | Despatch of a communication from the examining division (Time limit: M06) | 05.09.2022 | Reply to a communication from the examining division | Fees paid | Renewal fee | 11.06.2019 | Renewal fee patent year 03 | 29.06.2020 | Renewal fee patent year 04 | 14.06.2021 | Renewal fee patent year 05 | 31.03.2022 | Renewal fee patent year 06 | 31.03.2023 | Renewal fee patent year 07 | 17.05.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2007135380 (MEDICAL RES COUNCIL [GB], et al) [A] 1-15 * page 47; claim 1 *; | [XA]US2008021048 (BENNETT BRYDON L [US], et al) [X] 1-4,6 * page 109 - page 110; table 1; compounds 330-332 * * page 209; claim 1 * [A] 5,7-15; | [IA]WO2014135245 (MERCK PATENT GMBH [DE]) [I] 1-4,6-15 * page 149; claim 1 * * page 158; claim 15 *[A] 5 | International search | [A]US2010056494 (WINZELER ELIZABETH [US], et al) [A] 1-3, 8-11, 15-17, (25-27, 29-33, 35-54)/(1-3, 8-11, 15-17), 28/1, 34/1 * ; para [0007], [0054] *; | [A]WO2010059418 (GOVERNMENT OF THE U S A AS REP [US], et al) [A] 1-3, 8-11, 15-17, (25-27, 29-33, 35-54)/(1-3, 8-11, 15-17), 28/1, 34/1 * ; pg. 9, In 21-26, pg. 37, In 5-10, pg. 48, In 28-32 *; | [XA]US8440661 (BENNETT BRYDON L [US], et al) [X] 1-3, 8-11, 15-17, 25, 40)/(13, 8-11, 15-17) * ; col 47, Table 1, col 95, Table 1, col 175, Table 1, col 294, In 42-45, 49-64 * [A] (26-27, 29-33, 35-39, 41-54)/(1-3, 8-11, 15-17), 28/1, 34/1; | [A]US2016039822 (CLAREEN STEVEN [US], et al) [A] 1-3, 8-11, 15-17, (25-27, 29-33, 35-54)/(1-3, 8-11, 15-17), 28/1, 34/1* ; entire document * |